In developing the platform, we partnered with the frontline clinicians in an academic congenital heart canter, and adopted the agile software development approach with numerous rounds of formative evaluation and iterative refinement. Since 2013, this platform has been successfully used to meet the dynamic QI and research data needs of clinicians in the congenital heart center. Future work includes improving the efficiency and effectiveness of the platform and incorporating cutting-edge data interoperability standards.
Associate Professor, Ph.D
Biography: Dr. Kai Zheng is an Associate Professor in the Department of informatics at the University of California, Irvine. As a leading expert in the field of health informatics, Dr. Zheng is pioneering new ways of harnessing and utilizing information to improve health outcomes and maximize quality of life. Dr. Zheng's research has great emphasis on technology design as key to transforming healthcare. His work has the potential to impact people across the whole spectrum of care giving and receiving. As part of Dr. Zheng's research, he is creating intuitive, consumer-facing applications that empower people to take control over their own health and wellness management. Dr. Zheng was the primary PhD mentor of Dr. Wu and a faculty advisor of the proposed health IT innovation.
Title: Associate Professor
Advanced Degree(s): Ph.D
Biography: Dr. David Bradley is a Professor of Pediatrics at the University of Michigan, Ann Arbor. His research interests include interventional heart rhythm ablation techniques, pediatric device implantation, new pacing devices, postoperative arrhythmias, channelopathies, and sudden death prevention. Dr. Bradley is the lead of the Michigan Congenital Heart database team and a faculty advisor of the proposed health IT innovation.
Advanced Degree(s): MD
The data platform helps patients indirectly. By have all clinical data collected in a single place, quality improvement and clinical research can be easily conducted to improve care delivery and outcomes, as well as support evidence-based medicine.
The data platform is designed to facilitate direct data entry from physicians and other providers with high usability and workflow supporting. Providers therefore can have lower data entry burden, and potentially get higher quality of clinical data and gain more time with patients.
Some performance data cannot be collected in EHR systems and integrated with other clinical data. Hospital administration and leaders can therefore benefit from the data platform by collecting these data and receiving reports automatically generated on the platform. They also can avoid huge cost to work with EHR vendors to address their data needs.
The data platform can partner with EHR vendors. In this way, vendors can focus on improving their main product to better support clinical work and billing without worrying about clinicians' varied data needs.
In the year 2018, we plan to do a beta release of the data platform with a focus on improving its performance, enhancing its ability to discover patient cohorts, and incorporating cutting-edge data interoperability standards. We will seek more use cases and prove the generalizability and customizability of the platform.
Electronic Health Record system venders may enhance their produce's ability to support quality improvement and clinical research. However, these solutions may be costly, cumbersome, require a significant amount of vendor cooperation, and are difficult to maintain due to frequent vendor software upgrades and/or legal regulatory compliance. Existing software applications (e.g. REDCap) are either designed as standalone tools and are therefore difficult to integrate into clinicians’ workflow, or are largely redundant with EHRs, requiring a significant amount of double data entry. Our solution addresses these gaps as a companion software system that work side-by-side with an EHR to provide supplementary functionality in supporting research data capture.
We have filed software disclosure at the University of Cincinnati and University of Michigan.
No funding and partners as of 10/16/17.